Article
Biosimilar Litigation Review: Ongoing BPCIA District Court Cases To Watch
Authors
-
- Name
- Person title
- Associate
Fish principal Jenny Shmuel and associates Philip Chen and Felix Eyzaguirre recently wrote an article for Biosimilar Development discussing ongoing litigation under the Biosimilars Price Competition and Innovation Act (BPCIA) and new issues in 2019.
This is the first article in a four-part series focusing on 2019 legal developments related to the biosimilar sector.
Read the “Biosimilar Litigation Review: Ongoing BPCIA District Court Cases To Watch” full article.
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.